Nextcure to present at upcoming investor conferences

Beltsville, md., nov. 22, 2022 (globe newswire) -- nextcure, inc. (nasdaq: nxtc), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will present at the following investor conferences:
NXTC Ratings Summary
NXTC Quant Ranking